Ultrasound-guided foam sclerotherapy vs. open surgical ligation for incompetent perforator veins: a retrospective cohort study - Scorecard - MDSpire

Ultrasound-guided foam sclerotherapy vs. open surgical ligation for incompetent perforator veins: a retrospective cohort study

  • By

  • Rongjiang Li

  • Yongke Luo

  • Pin Lv

  • Zhe Ji

  • Xiong Lu

  • Haiwei Chen

  • May 29, 2026

  • 0 min

Share

Clinical Scorecard: Comparative Analysis of Ultrasound-Guided Foam Sclerotherapy and Open Surgical Ligation for Incompetent Perforator Veins: A Retrospective Cohort Investigation

At a Glance

CategoryDetail
ConditionIncompetent Perforator Veins (IPVs)
Key MechanismsUltrasound-guided foam sclerotherapy induces venous wall fibrosis and occlusion through chemical destruction of endothelial cells.
Target PopulationPatients aged ≥18 years diagnosed with IPVs, CEAP classification C4a to C6.
Care SettingRetrospective cohort study conducted at Baoji People’s Hospital.

Key Highlights

  • UGFS group had shorter operative time and less intraoperative blood loss compared to open surgery group.
  • Immediate occlusion rates were 100% in both UGFS and open surgery groups.
  • At 12 months, vein-level occlusion rate was higher in the open surgery group (95.3%) than in UGFS group (86.8%).
  • Total complication rate was lower in UGFS group (10.2%) compared to open surgery group (22.9%).
  • Independent risk factors for recanalization identified: perforator vein diameter >4.5 mm and BMI >27.2 kg/m2.

Guideline-Based Recommendations

Diagnosis

  • Preoperative diagnosis of IPVs by ultrasound, defined as perforator vein diameter >3.5 mm and reflux time >500 ms.

Management

  • Consider UGFS as a minimally invasive alternative to open surgical ligation for IPVs.

Monitoring & Follow-up

  • Follow-up for at least 12 months to assess vein occlusion rates and clinical outcomes.

Risks

  • Monitor for complications such as recanalization, especially in patients with identified risk factors.

Patient & Prescribing Data

97 patients with IPVs treated between February 2019 and February 2022.

Individualized treatment strategies based on patient-specific characteristics such as vein diameter and BMI.

Clinical Best Practices

  • Utilize ultrasound guidance to enhance injection precision during UGFS.
  • Assess and document preoperative perforator vein diameter and reflux time.
  • Provide thorough patient education regarding treatment options and expected outcomes.

Related Resources & Content

Original Source(s)

Related Content